Press release
Stroke Post Processing Software Market Hit US$ 417.53 Million by 2032 | Key Players: Siemens Healthineers; General Electric Company; Brainomix Limited; iSchemaView; Viz.ai Inc
Browse Full Report: https://www.factmr.com/report/stroke-post-processing-software-market
Why Is the Market Expanding?
The global stroke burden, with a 70% increase in incident cases from 1990 to 2019, drives demand for advanced diagnostic tools, as strokes cost over US$ 721 billion annually (0.66% of global GDP). AI and machine learning integration, adopted by 40% of stroke diagnostics in 2024, enhances detection accuracy by 20%, particularly for ischemic strokes, which account for 87% of cases. The rise in healthcare investments, with U.S. stroke-related costs reaching US$ 46 billion between 2014 and 2015, supports software deployment in hospitals and clinics, capturing 76% of market revenue. Innovations like iSchemaView's RAPID ANGIO, launched in 2019, improve acute stroke diagnosis by 15%. Regulatory support, such as FDA's 2024 AI diagnostic approvals, boosts adoption, while high costs (US$ 10,000-50,000 per license) are mitigated by cloud-based solutions, reducing expenses by 10%.
What Are the Key Market Projections?
The market is set to create an absolute dollar opportunity of US$ 239.53 million by 2032, growing from US$ 178 million in 2022 to US$ 417.53 million at an 8.9% CAGR. The MRI-based software segment, holding a 60% share in 2022, is projected to grow at a 9.2% CAGR, generating US$ 150 million in opportunities due to its precision in detecting ischemic strokes. North America, with a 47% share in 2022, leads with an 8.5% CAGR, driven by U.S. healthcare spending and collaborations like GE's 2021 partnership with Circle Neurovascular Imaging. Asia-Pacific, growing at a 9.5% CAGR, benefits from China's US$ 30 billion healthcare tech investments. Historical growth from 2015 to 2021 averaged a 9.2% CAGR, with acceleration expected. Short-term growth (2022-2026) focuses on hospitals, while long-term trends (2027-2032) emphasize mobile and tablet-based solutions, growing at an 8.7% CAGR.
How Can Stakeholders Capitalize on Opportunities?
Stakeholders in healthcare and technology sectors can leverage opportunities by investing in AI-driven software, like Brainomix's 2024 e-Stroke suite, enhancing diagnostic speed by 25%. Partnerships, such as Siemens Healthineers' 2020 collaboration with Stroke International Services for 3T MRI systems, expand market reach in Asia-Pacific, projected to account for 35% of demand by 2030. Focusing on cloud-based platforms, contributing 20% of revenue in 2022, ensures scalability and affordability. Compliance with FDA and EU IVDR standards boosts market trust, while targeting high-growth markets like India, with a 10% CAGR, unlocks potential. Developing mobile-based solutions, like Viz.ai's 2024 stroke detection app, addresses rural healthcare gaps, increasing adoption by 15%.
Want a Sample Before Buying? Download Free Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=7133
What Does the Report Cover?
Fact.MR's report analyzes the Stroke Post Processing Software Market across 30+ countries, covering segments by installation (desktop-based, mobile phones & tablet-based), modality (CT scan-based, MRI-based), software type (ischemic stroke, hemorrhagic stroke), end-use (hospitals & clinics, diagnostic centers, others), and region (North America, Latin America, Europe, Asia-Pacific, Middle East & Africa). It highlights trends like AI integration, cloud-based platforms, and point-of-care diagnostics. Combining primary research from industry experts and secondary data, the report provides actionable insights into market dynamics, competitive strategies, and growth opportunities through 2032.
Who Are the Market Leaders?
Key players include Siemens Healthineers, General Electric Company, Brainomix Limited, iSchemaView, and Viz.ai Inc. Siemens' 2020 MAGNETOM Lumina 3T MRI integration strengthened its diagnostic portfolio, while Brainomix's 2024 e-Stroke suite gained traction in Europe. These companies, holding over 50% of the market, drive innovation through R&D and partnerships, such as GE's 2021 FastStroke platform with Circle Neurovascular Imaging. Regional players like RapidAI focus on cost-effective solutions for Asia-Pacific, enhancing competitiveness. Strategic acquisitions, like iSchemaView's 2023 expansion of RAPID software, bolster market presence.
What Challenges and Solutions Exist?
High software costs (US$ 10,000-50,000 per license) and complex regulatory approvals, delaying launches by 12-18 months, pose challenges. Limited skilled radiologists, affecting 15% of facilities, and data privacy concerns, impacting 10% of deployments, hinder growth. Solutions include cloud-based platforms, reducing costs by 10%, and AI automation, improving diagnostic efficiency by 20%, as seen in Viz.ai's 2024 updates. Localized development in Asia-Pacific, adopted by 20% of providers, mitigates supply risks. Training programs, implemented by 15% of U.S. hospitals in 2024, address skill gaps. Compliance with HIPAA and GDPR standards ensures data security and market resilience.
What Are the Recent Developments?
In 2024, global stroke cases rose by 5%, boosting software demand by 10%, particularly for ischemic stroke diagnostics. North America's 47% share reflects U.S. advancements, with 129,624 genetic and imaging tests available in 2022.
Brainomix's 2024 e-Stroke suite, integrating AI for faster lesion detection, improved outcomes by 15%. Siemens Healthineers' 2024 syngo DynaCT Multiphase upgrade enhanced angiography precision by 12%. Asia-Pacific's growth, driven by China's 20% increase in healthcare tech funding, supports mobile-based software adoption, rising 18%. Regulatory advancements, like the EU's 2024 IVDR, increased compliant software deployment by 10%. Viz.ai's 2024 mobile app launch addressed rural stroke care, reducing diagnosis time by 20%.
Check out More Related Studies Published by Fact.MR:
Clientless Remote Support Software Market: https://www.factmr.com/report/345/clientless-remote-support-software-market
Diabetes Management Software Market: https://www.factmr.com/report/431/diabetes-management-software-market
Bone Marrow Processing System Market: https://www.factmr.com/report/1297/bone-marrow-processing-systems-market
Atrial Fibrillation Stroke Treatment Market: https://www.factmr.com/report/1716/atrial-fibrillation-stroke-treatment-market
Contact:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
About Fact.MR
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Stroke Post Processing Software Market Hit US$ 417.53 Million by 2032 | Key Players: Siemens Healthineers; General Electric Company; Brainomix Limited; iSchemaView; Viz.ai Inc here
News-ID: 4126855 • Views: …
More Releases from Fact.MR
Breast Biopsy Marker Market Set to Hit US$ 1.4 Billion by 2032 | Key Players: Ho …
The global Breast Biopsy Marker Market, valued at US$ 798 million in 2022, is projected to reach US$ 1.4 billion by 2032, driven by a robust CAGR of 5.8%. Fueled by the rising incidence of breast cancer, advancements in minimally invasive biopsy techniques, and increasing adoption of image-guided procedures, breast biopsy markers are critical for accurate diagnosis and treatment planning. This press release explores the key drivers, projections, and opportunities…
Drones Rescue Service Market is Growing at 15.2% CAGR | Key Players: Flyguys; Dr …
The global Drones Rescue Service Market, valued at US$ 547.6 million in 2023, is projected to reach US$ 2,254.1 million by 2033, driven by a robust CAGR of 15.2%. Fueled by the increasing adoption of drones for emergency response, advancements in AI and sensor technologies, and rising global disaster frequency, drone rescue services are transforming search and rescue operations. This press release explores the key drivers, projections, and opportunities shaping…
Undercarriage Components Market Expanding at USD 16.7 Billion by 2035 | Key Play …
The global Undercarriage Components Market, valued at USD 11.2 billion in 2025, is projected to reach USD 16.7 billion by 2035, driven by a steady CAGR of 4.1%. Fueled by surging demand for construction and agricultural machinery, infrastructure development, and advancements in undercarriage system technologies, this market is critical for ensuring the durability and efficiency of heavy equipment. This press release explores the key drivers, projections, and opportunities shaping this…
DNA Probes Based Diagnostics Market to Reach US$ 31.9 Billion by 2030 | Abbott L …
DNA Probes Based Diagnostics Market, having grown at a 4% CAGR from 2015 to 2019, is projected to reach US$ 31.9 billion by 2030, expanding at a CAGR of 5.1% from 2023 to 2030. Driven by rising demand for early and accurate diagnosis of infectious diseases, cancer, genetic predisposition, and forensic applications, DNA probe-based diagnostics are transforming healthcare with their high specificity and sensitivity. This press release explores the key…
More Releases for Stroke
Key Trends Reshaping the Acute Ischemic Stroke Diagnosis Market: Companies Revol …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Acute Ischemic Stroke Diagnosis Market Size Growth Forecast: What to Expect by 2025?
The market for diagnosing acute ischemic stroke has seen robust expansion in the last few years. The market size is forecasted to increase from $2.32 billion in 2024 to $2.48 billion in 2025, with a compound…
Stroke Diagnostics Market to Witness Robust Growth Amid Rising Stroke Incidence …
Market Overview
The stroke diagnostics market is estimated to be valued at USD 3.34 Bn in 2025 and is expected to reach USD 5.83 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.3% from 2025 to 2032.
Coherent Market Insights has released a comprehensive new report offering an in-depth analysis of the Stroke Diagnostics Market from 2025 to 2032. This study provides reliable global and regional projections, helping…
Key Trends Shaping the Future Acute Ischemic Stroke Diagnosis Market From 2025-2 …
Which drivers are expected to have the greatest impact on the over the acute ischemic stroke diagnosis market's growth?
The acute ischemic stroke diagnosis market is predicted to expand due to the growing number of acute ischemic stroke incidents. Acute ischemic stroke is a serious health emergency caused by inadequate blood flow to the brain, leading to brain cell damage. Prompt detection of acute ischemic stroke can assist in treatment, minimize…
Ischemic Stroke Aspiration Systems Market: Advancing Stroke Treatment with Innov …
Introduction
The ischemic stroke aspiration systems market is undergoing remarkable growth, driven by technological innovations and increasing awareness of advanced treatment options for stroke management. Ischemic stroke, the most common type of stroke, occurs when blood flow to a part of the brain is blocked, often due to a blood clot. This obstruction can lead to significant brain damage, disability, and even death if not treated swiftly. Aspiration systems, a vital…
Stroke Management Market Size To Reach USD 36.75 Billion, Globally, By 2023 | Di …
Asia-Pacific is expected to grow with the highest market share during the analysis period and would provide high opportunities for the market players.
The global stroke management market was valued at $22,581 million in 2016, and is estimated to reach $36,756 million by 2023, growing at a CAGR of 7.1% from 2017 to 2023. The diagnostics segment held more than five-seventh share of the total market in 2016.
Download Free Report Sample…
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to…
